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The ability to inhibit responses is critical for normal 
behavioral flexibility (Logan et al., 1984) and to direct 
behavior to achieve long-term goals (Nigg, 2000). Def-
icits in response inhibition are associated with several 
psychiatric disorders, such as attention deficit/hyper-
activity disorder (ADHD) (Schachar et al., 2000), and 
substance abuse (Vogel-Sprott et al., 2001; Fillmore and 
Rush, 2002). 
The serotonin system influences impulsivity in hu-
man beings and in other animals (Linnoila et al., 1983; 
Westergaard et al., 2003; Winstanley et al., 2003; Clarke 
et al., 2004). Impulsive aggression decreases with the ad-
ministration of drugs that raise serotonin levels (New et 
al., 2004), and impulsivity is increased by diets that re-
duce serotonin levels (Crean et al., 2002; Walderhaug et 
al., 2002). Studies have reported associations between 
serotonin system gene variants and ADHD (Hawi et 
al., 2002; Sheehan et al., 2005), impulsivity and suicid-
ality in major depressive disorder (Arango et al., 2001; 
Mann et al., 2001) and antisocial alcoholism (Hill et al., 
2002). Response inhibition has been localized to the pre-
frontal cortex (Aron and Poldrack, 2005), which is inner-
vated by serotonergic neurons. No studies to date have 
reported using a laboratory measure of response inhibi-
tion to examine potential associations with serotonergic 
genetic markers. 
The University of Michigan Medical School Institu-
tional Review Board approved this study. One hundred 
and ninety-nine participants (111 females, 88 males) (a) 
responded to advertisements offering $50 for 90 minutes 
of anonymous participation, (b) completed self-report 
questionnaires, (c) completed the Stop Task, and (d) do-
nated buccal cells. Their age ranged from 18 to 38 years 
(mean=20.8). Data for these analyses included the 67.8% 
(N = 135) self-identified as “White, not of Hispanic ori-
gin” (to control for population stratification). For multi-
variate analyses, only cases without missing data were 
included (final N = 109, 67 females; 42 males). 
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Abstract
The ability to inhibit a response is an important component of normal behavioral control and is an aspect of psychopathology when dimin-
ished. Converging evidence implicates the serotonergic neurotransmitter system in response inhibition circuitry. 
Objectives — The present study examined potential associations between serotonergic genetic markers and response inhibition as indexed 
by Stop Task performance. 
Methods — College-age participants (N= 199) completed self-report questionnaires, the computerized Stop Task, and donated buccal cells 
for genetic analyses. Statistics were analyzed by ANOVA. 
Results — Stop Signal reaction time was not associated with allelic variation at a monoamine oxidase A promoter length polymorphism or 
a serotonin 1B terminal autoreceptor polymorphism (G861C). An intronic genetic marker of the neuronal tryptophan hydroxylase-2 (the 
rate-limiting enzyme for serotonin biosynthesis) gene, however, was associated with the Stop Signal reaction time. Individuals homozygous 
for the T variant at an intron-8 polymorphism had the longest Stop Signal reaction time (i.e. greater impulsivity, P = 0.01), and this effect was 
stronger in males (P = 0.01) than in females (P = 0.10). 
Conclusions — A genotype at an intron-8 tryptophan hydroxylase-2 polymorphism was associated with response inhibition as indexed by the 
Stop Task. These results, if replicated, would implicate dorsal raphe serotonin neurons in response inhibition. It may be that individuals with 
the T/T genotype may have reduced tryptophan hydroxylase-2 function and correspondingly lower central serotonin levels; however, further 
investigation of the reported association is required.  
Keywords: serotonin, association study, impulsivity, stop task  
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For the Stop Task, an “X” or an “O” is displayed 
on a computer screen, and instructions are to respond 
rapidly by pressing one of two keys, depending on the 
visual stimulus. On 25% of trials, a tone [Stop Signal 
(SS)] sounds after the X or O appears, indicating that 
participants should withhold responding. The delay 
between the visual stimulus and the SS starts at 250 ms 
and is dynamically adjusted depending on the partici-
pant’s response. If a response was made, the delay for 
the next SS decreased by 50 ms (easier to inhibit); if no 
response was made, the delay for the next SS was sim-
ilarly increased (harder to inhibit). This delay yields a 
response inhibition rate of approximately 50% and pro-
vides reliable estimates of StopRT (Band et al., 2003). 
To calculate StopRT (an index of inhibitory control), 
average SS delay is subtracted from average GoRT. 
StopRT is related to normal variations in impulsivity 
(Logan et al., 1997) and to differences in behavioral in-
hibition in various psychopathologies (Nigg, 1999; Fill-
more and Rush, 2002; Nigg et al., 2002, 2004). Thus, the 
StopRT is useful for understanding both normal and 
impaired executive function. 
In all, there were 64 practice trials, followed by four 
blocks of 80 trials. We averaged the final four blocks un-
less, during a block, a participant inhibited responding 
on less than 30% or more than 70% of trials, which was 
taken as a failure to follow instructions. Data from only 
those “bad” blocks were discarded and the participant’s 
mean scores were based on the remaining blocks (Nigg, 
1999). Data from 15 participants were discarded in this 
manner. 
Average GoRT on trials without an SS was 483.40 ms. 
Males (459.24 ms) were faster, on average, than females 
[506.31 ms; F(1,107) = 4.43, P = 0.04]. Average StopRT was 
225.39 ms (males, 232.18 ms; females, 221.13 ms, NS). 
DNA extracted from buccal cells (Puregene Kit, Gen-
tra Systems, Minneapolis, Minnesota, USA) was used 
in polymerase chain reactions (PCRs) carried out in 20 
ml volume, using 2 μl genomic DNA, 200 μM of each 
dNTP, and 1.5 U Taq polymerase. PCR products were 
separated by electrophoresis in agarose gels and visual-
ized by ethidium bromide under ultraviolet light, except 
for the MAOA variable number tandem repeat (VNTR), 
which was separated by denaturing polyacrylamide gel 
electrophoresis. 
Serotonin 1B terminal autoreceptor (5-HTR1B) (6q13) 
is a G protein-linked receptor that appears to play a role 
in aggression, substance abuse and obsessive–compul-
sive disorder (Ramboz et al., 1996; Rocha et al., 1998; 
Veenstra-Vanderweele et al., 2000). These primers were 
used to assay the 5-HT1B G861C polymorphism: 5HT1B5 
5′ GAA ACA GAC GCC CAA CAG GAC; 5HT1B6 5′ 
CCA GAA ACC GCG AAA GAA GAT (Lappalainen 
et al., 1995). The amplification was carried out with 6.6 
pmol of each primer in buffer [TNK (Tris, ammonium, 
potassium): 50, 9.0 pH, 1.5 mM MgCl2] for 30 cycles 
(1 min at 90°C, 2 min at 60°C, and 3 min at 72°C), and 
products were digested using 2.5 U HincII (New Eng-
land Biolabs, Ipswich, Massachusetts, USA). 
MAOA is an enzyme that inactivates biogenic amines 
throughout the body (Xp11.23). Variants in the MAO 
promoter region and in the gene have been associated 
with impulsivity and aggression (Manuck et al., 2000). 
For the VNTR polymorphism in the monoamine oxidase 
A (MAOA) gene promoter region PCR, the following 
primers were used: MaoaPT1 5′ ACA GCC TGA CCG 
TGG AGA AG and MaoaPB1 5′ GAA CGG ACG CTC 
CAT TCG GA. Amplification was carried out with 20 
pmol of each primer in buffer [167 mM (NH4)2SO4, 670 
mM Tris pH 8.8, 20 mM MgCl2, 100 mM 2-mercaptoeth-
anol, 10 mg/ml bovine serum albumin], 1.2 M betaine, 
and 1% dimethylsulfoxide for 35 cycles (1 min at 94°C, 2 
min at 55°C, and 3 min at 72°C, with a final extension of 
10 min at 72°C). 
Tryptophan hydroxylase is the rate-limiting enzyme 
in serotonin synthesis. Association of variants in an in-
tron and in the promoter of tryptophan hydroxylase 
(TPH) have been found with impulsive-aggressive be-
havior, suicidality, ADHD, and depression-related traits 
(Nielsen et al., 1998; Tsai et al., 1999; Turecki et al., 2001; 
Sheehan et al., 2005). Recently, tryptophan hydroxylase-
2 (TPH2) (12q21.1) was found to be the main gene en-
coding TPH in the brain (Walther and Bader, 2003). For 
the intron-8 polymorphism (rs1386483) of TPH2 PCR, 
the following primers were designed: TPH2f-5′ GCT 
GGC TCT GAA CGT GTA TTT TG and TPH2r-5′ TTT 
GGC TGA TTT TCC TAA TTA AT (a mismatched base-
pair A generates a restriction site). Amplification was 
carried out with 20 pmol of each primer in buffer (TNK: 
50 pH 9.0, 1.5 mM MgCl2) for 35 cycles (1 min at 95°C, 2 
min at 53°C, and 3 min at 72°C), and products were di-
gested using 5.0 U SspI (New England Biolabs). 
Allele frequencies were calculated by pooling across 
sex, except for MAOA, which is located on the X chro-
mosome and therefore was examined separately by sex. 
For 5-HT1B G861C, G = 0.79, C = 0.21 (N = 52); for MAOA 
VNTR, males 1 = 0.48, 3 = 0.52 (N = 29), females 0 = 0.01, 
1 = 0.36, 3 = 0.63, 4 = 0.01 (N=52); for TPH2, T = 0.34, C 
= 0.66 (N=119). The markers were in Hardy–Weinberg 
equilibrium. Sample sizes varied because of difficulties 
in amplifying some samples. 
ANOVAs with Sex and Genotype as fixed effects and 
StopRT as the dependent variable were not significant 
for 5-HT1B and MAOA. For TPH2 (see Figure 1), both 
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Sex [F(1, 109) = 4.14, P = 0.04] and Genotype [F(2, 109) = 4.53, 
P = 0.01] were associated with StopRT and there was a 
significant Sex × Genotype interaction [F(2, 109) = 3.34, P 
= 0.04]. 
TPH2 is the rate-limiting enzyme for serotonin bio-
synthesis expressed in the dorsal raphe nucleus and is 
an important candidate gene for several psychiatric dis-
orders. For example, TPH2 variants are associated with 
ADHD (Sheehan et al., 2005), major depressive disorder 
(Zhang et al., 2005), suicide (Zill et al., 2004), and repeti-
tive behaviors in autism (Coon et al., 2005). 
We found that a TPH2 polymorphism was associated 
with response inhibition. Specifically, males with the T/
T genotype had the longest StopRTs, and among females 
there was a trend in that direction. The TPH2 associa-
tion with response inhibition remains statistically signif-
icant, after correction for multiple testing. We speculate 
that males with the T/T genotype have reduced neural 
TPH function and lower central serotonin levels. 
This finding adds to the converging evidence that 
TPH2 is associated with impulsivity. Our result, how-
ever, like all first reports on genetic association studies, 
needs to be replicated before generalization. 
The intronic SNP is more than 20 kb downstream of 
the previous exon, and 3.7 kb before the next exon. HAP-
MAP ( http://www.hapmap.org ) inspection shows that 
this SNP is in linkage disequilibrium with SNPs down-
stream, including some that are close to the exon 9 splice 
site, and it thus might affect splicing. In addition, it is in-
triguing that a functional, protein-coding TPH2 variant 
(which is not in HAPMAP) was recently reported to be 
associated with depression and SSRI response (Zhang et 
al., 2005). It is worth noting that substantial linkage dis-
equilibrium has been found along the TPH2 gene (Zill 
et al., 2004). Future research may address whether the 
T variant of the intron-8 polymorphism in TPH2 that 
we found associated with StopRT is in linkage disequi-
librium with the novel reduced function TPH2 variant. 
Our finding appears to be the first reported association 
between the brain-expressed TPH2 gene and a labora-
tory measure of impulsivity. 
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